Navigating End-of-Life Choices: The New York Medical Aid in Dying Act A profound shift in the conversation surrounding end-of-life autonomy has arrived in New York, as Governor Kathy Hochul has officially signed the amended Medical Aid in Dying Act into law. This landmark legislation, the result of
After years of escalating pressure and legislative debate, the Consolidated Appropriations Act of 2026 has finally landed, bringing with it a wave of reforms aimed at the powerful and often opaque world of Pharmacy Benefit Managers (PBMs). Employer groups, representing the health plans of more than
The quest for a safer method to prevent strokes has long been a paramount challenge in cardiovascular medicine, as current treatments often force a difficult trade-off between preventing blood clots and risking severe bleeding. In this high-stakes environment, a new class of anticoagulants known as
I'm joined today by Faisal Zain, a leading expert in U.S. healthcare policy with deep insights into hospital finance and pharmaceutical pricing. We're here to unpack the recent, and for many, welcome decision by the Department of Health and Human Services to scrap its controversial 340B
A New Dawn for Discretion in Men's Health The landscape of erectile dysfunction (ED) treatment has remained relatively unchanged for decades, dominated by oral tablets that have become household names. However, the recent FDA approval of Vybrique, the first and only oral dissolving film
A single piece of provincial legislation, passed in the waning days of 2025, has ignited a firestorm of debate that stretches far beyond Alberta's borders, forcing a national conversation about the very soul of Canadian health care. Officially titled the Health Amendment Act, Bill 11 was
